Insider Transactions in Q2 2021 at Kintara Therapeutics, Inc. (KTRA)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 29
2021
|
Robert Joseph Toth Jr Director |
BUY
Conversion of derivative security
|
Direct |
325
+17.19%
|
-
|
|
Apr 29
2021
|
Robert Joseph Toth Jr Director |
BUY
Other acquisition or disposition
|
Direct |
3
+0.24%
|
-
|
|
Apr 29
2021
|
Anthony Scott Praill Chief Financial Officer |
BUY
Conversion of derivative security
|
Direct |
938
+9.95%
|
-
|
|
Apr 29
2021
|
Anthony Scott Praill Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
8
+0.11%
|
-
|
|
Apr 29
2021
|
Dennis M Brown Chief Scientific Officer |
BUY
Conversion of derivative security
|
Direct |
750
+9.91%
|
-
|
|
Apr 29
2021
|
Dennis M Brown Chief Scientific Officer |
BUY
Other acquisition or disposition
|
Direct |
6
+0.1%
|
-
|